Disrupting phosphatase SHP2 in macrophages protects mice from high-fat diet-induced hepatic steatosis and insulin resistance by elevating IL-18 levels
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 295 (31), 10842-10856
- https://doi.org/10.1074/jbc.ra119.011840
Abstract
No abstract availableKeywords
Funding Information
- NSFC (91853109, 81872877, 81673436)
- NSFC (81970709)
- NSFC (81922067)
- NSFC (81730100)
This publication has 42 references indexed in Scilit:
- Interleukin-18 in Health and DiseaseInternational Journal of Molecular Sciences, 2019
- Obesity and metabolic inflammationDrug Discovery Today: Disease Mechanisms, 2013
- Inflammation links excess fat to insulin resistance: the role of the interleukin‐1 familyImmunological Reviews, 2012
- Type 2 diabetes as an inflammatory diseaseNature Reviews Immunology, 2011
- Interleukin-1 beta targeted therapy for type 2 diabetesExpert Opinion on Biological Therapy, 2009
- Inflammation and insulin resistanceFEBS Letters, 2007
- Obesity, Inflammation, and Insulin ResistanceGastroenterology, 2007
- Interleukin-1–Receptor Antagonist in Type 2 Diabetes MellitusThe New England Journal of Medicine, 2007
- Interleukin-1β-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 ExpressionEndocrinology, 2007
- Inflammatory Cytokines and the Risk to Develop Type 2 DiabetesDiabetes, 2003